Dyne Therapeutics: Funding, Investors & Team (Oct 2026)
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.The company's therapies deliver nucleic acids and other molecules to skeletal, cardiac and smooth muscle with unprecedented precision, enabling patients to restore muscle strength and transform their lives.
Dyne Therapeutics has raised $200M across 1 funding round on record, the most recent an undisclosed round of $200M announced in Jun 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Dyne Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Dyne Therapeutics Funding Rounds
Dyne Therapeutics Founders and Leadership Team
Contact details for the Dyne Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Dyne Therapeutics Funding Compared to Other Biotechnology Startups
Dyne Therapeutics' latest round of $200M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Dyne Therapeutics in Biotechnology and Cambridge
Companies Similar to Dyne Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Dyne Therapeutics Funding FAQs
What does Dyne Therapeutics do?
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.The company's therapies deliver nucleic acids and other molecules to skeletal, cardiac and smooth muscle with unprecedented precision, enabling patients to restore muscle strength and transform their lives.
How much funding has Dyne Therapeutics raised?
Dyne Therapeutics has raised $200M across 1 round on record. The most recent is an undisclosed round of $200M announced in Jun 2026.
When did Dyne Therapeutics last raise funding?
Dyne Therapeutics' most recent funding round on record is an undisclosed round of $200M, announced in Jun 2026.
Who founded Dyne Therapeutics?
FundedIQ lists John Cox (Founder) at Dyne Therapeutics.
Where is Dyne Therapeutics headquartered?
Dyne Therapeutics is based in Cambridge, Massachusetts, United States.
How many employees does Dyne Therapeutics have?
Dyne Therapeutics is in the 101-250 employee band.
How does Dyne Therapeutics' funding compare to other Biotechnology startups?
Dyne Therapeutics' latest round of $200M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Dyne Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Dyne Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.